Log In
Print this Print this

G1T28 (formerly IV G1T28-1)

  Manage Alerts
Collapse Summary General Information
Company G1 Therapeutics Inc.
DescriptionIV formulation of a selective inhibitor of cyclin dependent kinase 4 (CDK4) and CDK6
Molecular Target Cyclin dependent kinase 4 (CDK4) ; Cyclin dependent kinase 6 (CDK6)
Mechanism of ActionCyclin dependent kinase 4 (CDK4) inhibitor; Cyclin dependent kinase 6 (CDK6) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today